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Sir,
I welcome the contributions of Heng et al and Lawson et al in
the October 2009 issue of the British Journal of Cancer. I would like
to comment on the article submitted by Lawson et al, ‘Koilocytes
indicate a role for human papilloma virus in breast cancer’. The
authors cite an earlier article in which I was a participating author
and refer to the koilocytes identified in our article as ‘putative
(supposed) HPV-associated koilocytes’. The concept of koilocy-
tosis was initially and arguably still remains a morphological
construct (Reid et al, 1982). In the early 1990s, based on a
systematic and careful review of routine breast cancer specimens,
which included areolar and nipple tissue, Buck and I submitted,
for publication, a select series of breast cancer cases with
koilocytosis in the nipple and areola. The initial attempts at
publication were rejected because of an absence of molecular
confirmation of the presence of human papilloma virus (HPV).
Subsequently, with de Villiers (Buck et al, 2001), we reported a
limited series of areola and nipple specimens with histological
evidence of koilocytosis confirmed by polymerase chain reaction
(PCR). In a larger series, joined by zur Hausen (de Villiers et al,
2005), we published a series of cases including both nipple and
areolar specimens and associated breast cancer tissue. In that
report, both PCR and in situ hybridization were used to confirm
the presence of the viral DNA in koilocytes. We demonstrated the
co-localization by in situ hybridization with histological evidence
of koilocytosis. Our confirmatory methods were in essence
identical to those used by Lawson et al.
Recent identification of HPV by PCR in breast milk, ductal lavage
and colostrum specimens is not cited by Lawson et al (Sarkola et al,
2008; Cazzaniga et al, 2009). Human papilloma virus was detected in
4 and 14% of non-selected breast milk specimens. Although the
authors identified low numbers of positive HPV samples, the time-
specific incidence of HPV positivity is of the same order of
magnitude as encountered in cervical specimens of sexually active
women and, to my mind, implies a relatively high aggregate lifetime
likelihood of HPV colonization of the nipple and/or areola.
Cazzaniga et al have argued that scraping the superficial layers of
the nipple decreased the number of positive samples. However, the
argument can be made that this may reflect the natural history of
HPV in that virus accumulates through the course of keratinizing
cell maturation from the basal layer to the superficial layer. It has
been documented that sampling from the surface of skin tumours
after striping the biopsy with an adhesive tape decreases the
likelihood of isolating the virus by PCR (Forslund et al, 2004).
The presence of the virus in breast milk specimens supports the
likelihood that HPV infects the nipple and areolar tissue and
indirectly supports the concept of HPV-specific koilocytosis at these
sites. I hope I will be allowed some latitude for speculation in this
regard. There is the possibility that HPV transmission in the
neonatal period in breast milk or colostrum through immune
modulation and oral induced tolerance (Strobe et al,2 0 0 1 ;
Lawrence and Lawrence, 2004) may modify host immune response
to the virus encountered later in life. This speculative construct may
further complicate and enrich the pathophysiological mechanism
that Buck et al initially postulated that HPV infection as evidenced
by koilocytosis affecting the nipple, areola and duct structures may
be related to the induction of neoplasia in breast tissue by
retroductular spread of the virus.
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